Mersana Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Mersana Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Mersana Therapeutics Inc
Rating: 1.12133325
Author: Trendlyne DVM scores

about

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

7.47 0.12 (1.63%)

89.44% Fall from 52W High

30,561

XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Bearish

30.0 / 100

1Yr Price target upside is 279%

7 analysts

Mersana Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mersana Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

89.44% Fall from 52W High

SWOT Analysis

Mersana Therapeutics Inc Live Price Chart